2026 Taiwan guidelines for the acute pharmacologic treatment of migraine in adults

{"Since":[0],"the":[1,4,11,22,37,41,58,154,194,306],"publication":[2],"of":[3,14,24,40,75,85,157,196,260,308],"Taiwan":[5,28,42,90],"Headache":[6,43],"Society's":[7],"2022":[8],"Guidelines":[9],"for":[10,47,91,201,217,244,277],"Acute":[12],"Treatment":[13,191],"Migraine":[15],"Attacks,":[16],"advances":[17],"in":[18,27,89],"headache":[19],"medicine":[20],"and":[21,49,62,65,78,98,105,108,122,141,171,187,212,229,279,294],"approval":[23],"new":[25],"drugs":[26,125],"have":[29,253],"necessitated":[30],"an":[31],"update.":[32],"To":[33,282],"address":[34],"clinical":[35],"needs,":[36],"Guideline":[38],"Committee":[39],"Society":[44],"reviewed":[45],"evidence":[46,186],"pharmacological":[48],"non-pharmacological":[50],"acute":[51,92,286],"treatments":[52,102],"using":[53],"evidence-based":[54],"principles.":[55],"Drawing":[56],"from":[57],"latest":[59],"European,":[60],"American,":[61],"international":[63],"guidelines,":[64],"through":[66],"expert":[67],"consensus,":[68],"this":[69],"revision":[70],"updates":[71],"treatment":[72],"roles,":[73],"grades":[74],"recommendation,":[76],"efficacy,":[77],"adverse-effect":[79],"profiles.":[80],"Currently,":[81],"a":[82,240],"broad":[83],"range":[84],"medications":[86],"is":[87,132,148],"available":[88],"migraine":[93],"management,":[94],"categorised":[95],"into":[96],"\\"specific\\"":[97],"\\"non-specific\\"":[99],"agents.":[100],"Specific":[101],"include":[103,120],"oral":[104,111,176,199,213],"intranasal":[106,215],"triptans,":[107,252,291],"gepants,":[109],"i.e.,":[110],"calcitonin":[112],"gene-related":[113],"peptide":[114],"(CGRP)":[115],"receptor":[116],"antagonists.":[117],"Non-specific":[118],"agents":[119,169],"acetaminophen":[121],"non-steroidal":[123],"anti-inflammatory":[124],"(NSAIDs:":[126],"diclofenac,":[127],"ibuprofen,":[128],"naproxen).":[129],"Injectable":[130],"prochlorperazine":[131],"also":[133],"strongly":[134],"recommended.":[135,190],"Ergotamine/caffeine":[136],"combinations":[137,162],"are":[138,142,188,247,257,272],"less":[139],"effective":[140],"second-line":[143],"agents,":[144],"while":[145],"high-dose":[146],"aspirin":[147],"limited":[149,174],"by":[150],"gastrointestinal":[151],"risk.":[152],"Considering":[153],"potential":[155],"risk":[156,259],"dependency,":[158],"tramadol":[159],"or":[160,207,214,249,256],"tramadol/paracetamol":[161],"should":[163,172,192,297],"be":[164,173,227,238],"reserved":[165],"until":[166],"all":[167],"other":[168],"fail,":[170],"to":[175,219,251],"forms.":[177],"Other":[178],"opioids,":[179],"such":[180],"as":[181,210],"morphine,":[182],"butorphanol,":[183],"etc.,":[184],"lack":[185],"not":[189,298],"follow":[193],"principle":[195],"stratified":[197],"care:":[198],"NSAIDs":[200,209,233],"mild":[202],"disability,":[203,221],"with":[204,232,269,305],"combination":[205,295],"analgesics":[206],"parenteral":[208,267],"alternatives,":[211],"triptans":[216,231],"moderate":[218],"severe":[220],"ideally":[222],"administered":[223],"early.":[224],"Antiemetics":[225],"may":[226],"added,":[228],"combining":[230],"enhances":[234],"efficacy.":[235],"Rimegepant":[236],"can":[237],"considered":[239],"first-line":[241,276],"therapy,":[242],"particularly":[243],"patients":[245],"who":[246],"unresponsive":[248],"intolerant":[250],"cardiovascular":[254],"contraindications,":[255],"at":[258],"developing":[261],"medication":[262],"overuse.":[263],"In":[264],"status":[265],"migrainosus,":[266],"corticosteroids":[268],"intravenous":[270],"fluids":[271],"advised.":[273],"Acetaminophen":[274],"remains":[275],"children":[278],"pregnant":[280],"women.":[281],"prevent":[283],"medication-overuse":[284],"headache,":[285],"treatments,":[287],"including":[288],"NSAIDs,":[289],"acetaminophen,":[290],"ergot":[292],"derivatives,":[293],"analgesics,":[296],"exceed":[299],"two":[300],"days":[301],"per":[302],"week,":[303],"probably":[304],"exception":[307],"rimegepant.":[309]}